In a 35‑year‑old woman with four months of intermittent facial erythema confined to the cheeks and no systemic manifestations, could this represent systemic lupus erythematosus?

Could This Be Lupus?

Yes, intermittent facial erythema confined to the cheeks in a 35-year-old woman could represent systemic lupus erythematosus (SLE), though the absence of systemic manifestations after four months makes isolated cutaneous lupus erythematosus (CLE) more likely at this stage.

Diagnostic Considerations

The clinical presentation warrants systematic evaluation because:

• Facial erythema is a common presenting feature of lupus, with malar (butterfly) rash occurring in approximately 51% of SLE patients and representing one of the classic acute cutaneous lupus manifestations 1
• Isolated cutaneous disease can precede systemic involvement by months to years, as chronic discoid lesions preceded systemic disease in 15% of patients in one cohort 1
• Unilateral or atypical facial erythema has been documented as an uncommon but recognized presentation of SLE, which can impose diagnostic challenges and may initially be misdiagnosed as other dermatoses 2

Key Clinical Features to Assess

Determine whether this represents specific lupus-related cutaneous disease versus non-specific manifestations:

• Pattern and distribution: Classic malar rash spares the nasolabial folds, while the erythema may present with telangiectasia or papulosquamous features 1
• Photosensitivity: Approximately 63% of SLE patients report photosensitivity, and worsening after sun exposure strongly suggests lupus 1
• Duration of individual lesions: Urticarial lesions in lupus often persist beyond 36 hours, unlike typical urticaria 1
• Associated features: Look specifically for oral ulcers (present in 31.5% at some point, with 15% having them at disease onset), non-scarring alopecia (40%), or Raynaud's phenomenon (60%) 1

Essential Workup

Proceed with targeted laboratory and histologic evaluation:

• Skin biopsy from affected area: Histopathologic examination is key in diagnostically difficult cases and can confirm lupus-specific changes even when clinical features are atypical 2, 3
• Autoantibody panel: Check ANA, anti-dsDNA, anti-Smith, anti-Ro/SSA, and anti-La/SSB to assess for systemic disease risk 4
• Complete blood count: Screen for thrombocytopenia, leukopenia, or lymphopenia 2
• Urinalysis with microscopy: Evaluate for proteinuria or cellular casts indicating renal involvement 2
• Complement levels (C3, C4): Low levels suggest active systemic disease 4

Common Pitfalls to Avoid

• Do not dismiss unilateral or atypical presentations: Unilateral facial erythema, while uncommon, has been documented as a presenting sign of SLE and may mimic cellulitis, blepharitis, or other dermatoses 2
• Recognize that cutaneous-only disease at presentation does not exclude future systemic involvement: Chronic cutaneous LE preceded systemic disease in a significant minority of patients 1
• Consider alternative diagnoses: Facial erythema with swelling can represent dermatomyositis, rosacea, or Morbihan disease, requiring complete evaluation to differentiate 5

Management Framework If Lupus Is Confirmed

Should the workup confirm lupus erythematosus:

• Hydroxychloroquine is recommended for all lupus patients at a dose not exceeding 5 mg/kg real body weight, regardless of whether disease is limited to skin or systemic 4
• Photoprotection is essential given the high prevalence of photosensitivity and UV-induced disease flares 4, 3
• Serial monitoring for systemic manifestations is necessary, as cutaneous disease can evolve over time 4